Apnimed

APMD · NASDAQ

$18.51+$1.92 (+11.54%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $16.60

Latest news

Press releaseOct 12, 4:05 PM ETGlobe Newswire
Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
NewsSep 8, 4:41 PM ET
Apnimed Q2 EPS $3.91 Beats $(0.34) Estimate, Sales $12.080M
Press releaseSep 8, 4:39 PM ETGlobe Newswire
Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update
NewsAug 3, 8:01 AM ETAvi Kapoor
AstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
NewsAug 3, 4:33 AM ETAvi Kapoor
Why Atkore Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
Press releaseJul 30, 10:10 PM ETPRNewswire
Apnimed Announces Pricing of Upsized Initial Public Offering

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026

Apnimed Q2 EPS $3.91 Beats $(0.34) Estimate, Sales $12.080M

Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update

AstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

Why Atkore Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket

Apnimed Announces Pricing of Upsized Initial Public Offering